Most Recent

image: Contributors

Contributors

By | June 1, 2016

Meet some of the people featured in the June 2016 issue of The Scientist.

0 Comments

image: Do Patents Promote or Stall Innovation?

Do Patents Promote or Stall Innovation?

By | June 1, 2016

A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.

3 Comments

image: Enhancing Vaccine Development

Enhancing Vaccine Development

By | June 1, 2016

Using proteomics methods to inform antigen selection

1 Comment

image: Finding Mislabeled Noncoding RNAs

Finding Mislabeled Noncoding RNAs

By | June 1, 2016

Researchers scour the genome for micropeptides encoded within RNAs presumed to function in a noncoding capacity.

0 Comments

image: Questions Over <em>C. elegans</em> Life Span Factors

Questions Over C. elegans Life Span Factors

By | June 1, 2016

A recent paper challenges earlier findings that germline factors expressed in normal body cells influence life span in C. elegans.

0 Comments

image: Research at Micro- and Nanoscales

Research at Micro- and Nanoscales

By | June 1, 2016

From whole cells to genes, closer examination continues to surprise.  

1 Comment

image: Screening  with CRISPR

Screening with CRISPR

By | June 1, 2016

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Students Study Their Own Microbiomes

Students Study Their Own Microbiomes

By | June 1, 2016

Pooping into a petri dish is becoming standard practice as part of some college biology courses.

0 Comments

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Noncoding RNAs Not So Noncoding

Noncoding RNAs Not So Noncoding

By | June 1, 2016

Bits of the transcriptome once believed to function as RNA molecules are in fact translated into small proteins.

3 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech